http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2011532-C

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
filingDate 1990-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3762ff3a63e1adad3aef4cc0e7f668b
publicationDate 2000-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2011532-C
titleOfInvention Formulation
abstract Pharmaceutical formulations for the parenteral administration of 1-isobutyl-1H-imidazo[4,5-c)quinolin-9-amine or 1-(2-hydroxy-2-methylpropyl)-1-H-imidazo(4,5-c) quinolin-4-amine are described.
priorityDate 1989-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12255326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431944402
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665726
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154343428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449125874
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448367864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452339473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13982876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415828063
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432430528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68476
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154101246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780

Total number of triples: 60.